Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2024Journal of Advances in Medicine and Medical ResearchOpen Access

Implementation of Targeted Axillary Node Assessment Following Neoadjuvant Therapy for Node-positive Breast Cancer Patients Improves Axillary Disease Detection

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRufina SoomroAKAfsheen Javaid KhokherSNSadaf Nasir

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Soomro et al. (2024) studied this question.

synapsesocial.com/papers/68e751b8b6db6435876c9b34https://doi.org/10.9734/jammr/2024/v36i45396
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Management of the axilla after neoadjuvant chemotherapy in breast cancer patients2021 · 8 citations
  2. 2Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy2007 · 1,695 citations
  3. 3Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor2014 · 25 citations
  4. 4Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study2014 · 862 citations
  5. 5The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis2021 · 87 citations